Tag Archives: crispr

The global rise in antibiotic resistance is making bacterial infections harder to treat and increasing the risk of disease spread, severe illness, and death. Once considered miracle drugs, antibiotics are now losing their effectiveness against ever-evolving bacteria. One company is aiming to treat infections with a different strategy: arming tiny …

Last year, startup Pairwise started selling the first food in the US made with Crispr technology: a new type of mustard greens with an adjusted flavor. But chances are, most consumers never got to sample them. The company introduced the greens to the food service industry—select restaurants, cafeterias, hotels, retirement …

In a world first, surgeons in Boston have transplanted a genetically altered pig kidney into a 62-year-old man. The procedure is a step toward providing more readily available organs to patients who are in desperate need of a transplant. The four-hour surgery was carried out on March 16 at Massachusetts …

At the end of 2023, we witnessed an important moment in the history of medicine: For the first time, the US Food and Drug Administration approved a therapy that uses Crispr gene editing. This new therapy was developed by Crispr Therapeutics and Vertex Pharmaceuticals to treat sickle cell disease, an …

Jimi Olaghere used to end up in the emergency room so often that the hospital reserved a bed for him. Sickle cell disease dominated his life. A genetic defect he was born with meant that instead of having flexible, round red blood cells like most people do, his were sticky …

It’s been a monumental year for Crispr, the molecular tool scientists use to edit genetic material. This November, the United Kingdom authorized the first medical treatment using Crispr gene editing, giving people with sickle cell disease new opportunities to receive a one-time therapy to prevent episodes of terrible pain. This …

The first medical treatment that uses Crispr gene editing was authorized Thursday by the United Kingdom. The one-time therapy, which will be sold under the brand name Casgevy, is for patients with sickle cell disease and a related blood disorder called beta thalassemia, both of which are inherited. The UK …

In a small initial test in people, researchers have shown that a single infusion of a novel gene-editing treatment can reduce cholesterol, the fatty substance that clogs and hardens arteries over time. The experiment was carried out in 10 participants with an inherited condition that causes extremely high LDL, or …